{"id":62895,"date":"2026-04-07T01:02:20","date_gmt":"2026-04-06T23:02:20","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/"},"modified":"2026-04-07T01:02:20","modified_gmt":"2026-04-06T23:02:20","slug":"diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/","title":{"rendered":"Diversified Healthcare Trust First Quarter 2026 Conference Call Scheduled for Tuesday, May 5th"},"content":{"rendered":"<div>\n<p>NEWTON, Mass.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.dhcreit.com&amp;esheet=54480500&amp;newsitemid=20260406358767&amp;lan=en-US&amp;anchor=Diversified+Healthcare+Trust+%28Nasdaq%3A+DHC%29&amp;index=1&amp;md5=235d947ea3000640da285abecffe1aa4\" rel=\"nofollow\" shape=\"rect\">Diversified Healthcare Trust (Nasdaq: DHC)<\/a> today announced that it will issue a press release containing its first quarter 2026 financial results after the Nasdaq closes on Monday, May 4, 2026. On Tuesday, May 5, 2026 at 10:00 a.m. Eastern Time, President and Chief Executive Officer <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dhcreit.com%2Fabout-us%2Fleadership%2Fsenior-management%2Fchris-bilotto%2Fdefault.aspx&amp;esheet=54480500&amp;newsitemid=20260406358767&amp;lan=en-US&amp;anchor=Christopher+Bilotto&amp;index=2&amp;md5=f6ad4436d0913738d7957c13594657ea\" rel=\"nofollow\" shape=\"rect\">Christopher Bilotto<\/a>, Chief Financial Officer and Treasurer <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dhcreit.com%2Fabout-us%2Fleadership%2Fsenior-management%2Fmatthew-brown%2Fdefault.aspx&amp;esheet=54480500&amp;newsitemid=20260406358767&amp;lan=en-US&amp;anchor=Matthew+Brown&amp;index=3&amp;md5=c9bf0454e23039db26e022c1a970dc6c\" rel=\"nofollow\" shape=\"rect\">Matthew Brown<\/a> and Vice President <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dhcreit.com%2Fabout-us%2Fleadership%2Fsenior-management%2Fanthony-paula%2Fdefault.aspx&amp;esheet=54480500&amp;newsitemid=20260406358767&amp;lan=en-US&amp;anchor=Anthony+Paula&amp;index=4&amp;md5=d9d7452d81df0fbf9d525be95fddaf00\" rel=\"nofollow\" shape=\"rect\">Anthony Paula<\/a> will host a conference call to discuss these results.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20260406358767\/en\/767737\/5\/DHC_logo-rgb-webres.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260406358767\/en\/767737\/22\/DHC_logo-rgb-webres.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20260406358767\/en\/767737\/5\/DHC_logo-rgb-webres.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260406358767\/en\/767737\/21\/DHC_logo-rgb-webres.jpg\"><\/a><\/p>\n<p>\nThe conference call telephone number is (877) 329-4297. Participants calling from outside the United States and Canada should dial (412) 317-5435. No pass code is necessary to access the call from either number. Participants should dial in about 15 minutes prior to the scheduled start of the call. A replay of the conference call will be available through 11:59 p.m. Eastern Time on Tuesday, May 12, 2026. To hear the replay, dial (855) 669-9658. The replay pass code is 1482489.<\/p>\n<p>\nA live audio webcast of the conference call will also be available in a listen-only mode on the company\u2019s website, which is located at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.dhcreit.com%2Finvestors%2Fevents-and-presentations%2Fdefault.aspx&amp;esheet=54480500&amp;newsitemid=20260406358767&amp;lan=en-US&amp;anchor=www.dhcreit.com&amp;index=5&amp;md5=e72b8042307c66abb2110d53bb705faf\" rel=\"nofollow\" shape=\"rect\">www.dhcreit.com<\/a>. Participants wanting to access the webcast should visit the company\u2019s website about five minutes before the call. The archived webcast will be available for replay on the company\u2019s website after the call.<\/p>\n<p>\n<b>About Diversified Healthcare Trust<\/b><\/p>\n<p>\nDHC is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of December 31, 2025, DHC\u2019s approximately $6.3 billion portfolio included 298 properties in 33 states and Washington, D.C., with approximately 25,000 senior living units, approximately 5.6 million square feet of medical office and life science properties and occupied by approximately 290 tenants. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with over $37 billion in assets under management as of December 31, 2025 and 40 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.dhcreit.com&amp;esheet=54480500&amp;newsitemid=20260406358767&amp;lan=en-US&amp;anchor=www.dhcreit.com&amp;index=6&amp;md5=0e1a7502599f40c3d3560d9554501c7f\" rel=\"nofollow\" shape=\"rect\">www.dhcreit.com<\/a>.<\/p>\n<p class=\"bwalignc\">\nA Maryland Real Estate Investment Trust with transferable shares of beneficial interest listed on the Nasdaq.<br \/>\n<br \/>No shareholder, Trustee or officer is personally liable for any act or obligation of the Trust.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nBryan Maher, Senior Vice President<br \/>\n<br \/>(617) 796-8234<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEWTON, Mass.&#8211;(BUSINESS WIRE)&#8211;Diversified Healthcare Trust (Nasdaq: DHC) today announced that it will issue a press release containing its first quarter 2026 financial results after the Nasdaq closes on Monday, May 4, 2026. On Tuesday, May 5, 2026 at 10:00 a.m. Eastern Time, President and Chief Executive Officer Christopher Bilotto, Chief Financial Officer and Treasurer Matthew &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62895","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Diversified Healthcare Trust First Quarter 2026 Conference Call Scheduled for Tuesday, May 5th - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Diversified Healthcare Trust First Quarter 2026 Conference Call Scheduled for Tuesday, May 5th - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEWTON, Mass.&#8211;(BUSINESS WIRE)&#8211;Diversified Healthcare Trust (Nasdaq: DHC) today announced that it will issue a press release containing its first quarter 2026 financial results after the Nasdaq closes on Monday, May 4, 2026. On Tuesday, May 5, 2026 at 10:00 a.m. Eastern Time, President and Chief Executive Officer Christopher Bilotto, Chief Financial Officer and Treasurer Matthew ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-06T23:02:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260406358767\/en\/767737\/22\/DHC_logo-rgb-webres.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Diversified Healthcare Trust First Quarter 2026 Conference Call Scheduled for Tuesday, May 5th\",\"datePublished\":\"2026-04-06T23:02:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\\\/\"},\"wordCount\":393,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260406358767\\\/en\\\/767737\\\/22\\\/DHC_logo-rgb-webres.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\\\/\",\"name\":\"Diversified Healthcare Trust First Quarter 2026 Conference Call Scheduled for Tuesday, May 5th - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260406358767\\\/en\\\/767737\\\/22\\\/DHC_logo-rgb-webres.jpg\",\"datePublished\":\"2026-04-06T23:02:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260406358767\\\/en\\\/767737\\\/22\\\/DHC_logo-rgb-webres.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260406358767\\\/en\\\/767737\\\/22\\\/DHC_logo-rgb-webres.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diversified Healthcare Trust First Quarter 2026 Conference Call Scheduled for Tuesday, May 5th\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Diversified Healthcare Trust First Quarter 2026 Conference Call Scheduled for Tuesday, May 5th - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/","og_locale":"en_US","og_type":"article","og_title":"Diversified Healthcare Trust First Quarter 2026 Conference Call Scheduled for Tuesday, May 5th - Pharma Trend","og_description":"NEWTON, Mass.&#8211;(BUSINESS WIRE)&#8211;Diversified Healthcare Trust (Nasdaq: DHC) today announced that it will issue a press release containing its first quarter 2026 financial results after the Nasdaq closes on Monday, May 4, 2026. On Tuesday, May 5, 2026 at 10:00 a.m. Eastern Time, President and Chief Executive Officer Christopher Bilotto, Chief Financial Officer and Treasurer Matthew ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/","og_site_name":"Pharma Trend","article_published_time":"2026-04-06T23:02:20+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260406358767\/en\/767737\/22\/DHC_logo-rgb-webres.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Diversified Healthcare Trust First Quarter 2026 Conference Call Scheduled for Tuesday, May 5th","datePublished":"2026-04-06T23:02:20+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/"},"wordCount":393,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260406358767\/en\/767737\/22\/DHC_logo-rgb-webres.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/","url":"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/","name":"Diversified Healthcare Trust First Quarter 2026 Conference Call Scheduled for Tuesday, May 5th - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260406358767\/en\/767737\/22\/DHC_logo-rgb-webres.jpg","datePublished":"2026-04-06T23:02:20+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260406358767\/en\/767737\/22\/DHC_logo-rgb-webres.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260406358767\/en\/767737\/22\/DHC_logo-rgb-webres.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/diversified-healthcare-trust-first-quarter-2026-conference-call-scheduled-for-tuesday-may-5th\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Diversified Healthcare Trust First Quarter 2026 Conference Call Scheduled for Tuesday, May 5th"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62895"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62895\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}